Jia xiang Jin; Britta Besemer; Büsranur Yilmaz; Mathias Hänel; Roland Fenk; Uta Bertsch; Kaarina-Jiayuan Gu; Christine Hanoun; Igor W. Blau; Christoph Mann; Christof Scheid; Roland Schroers; Ivana von Metzler; Manfred Hensel; Eva-Maria Klein; Martin Hoffmann; Christoph Lutz; Hendrik Riesenberg; Uwe M. Martens; Christian S. Michel; Christian Kunz; Evgenii Shumilov; Deniz Gezer; Tobias A. W. Holderried; Karolin Trautmann-Grill; Carsten Müller-Tidow; Katja C. Weisel; Marc S. Raab; Hans J. Salwender; Hartmut Goldschmidt; Elias K. Mai

Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT

TKI和CPI一线治疗策略在晚期肾细胞癌中的头对头比较——来自德国研究平台CARAT的真实世界数据

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2025-10-010

OAAI

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024)

ESMO OPEN

IF8.3

2024-10-010

OAAI

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

NATURE COMMUNICATIONS

IF15.7

2024-08-113

OAAI

Latzer, Pauline; Zelba, Henning; Battke, Florian; Reinhardt, Annekathrin; Shao, Borong; Bartsch, Oliver; Rabsteyn, Armin; Harter, Johannes; Schulze, Martin; Okech, Thomas; Golf, Alexander; Kyzirakos-Feger, Christina; Kayser, Simone; Pieper, Natalia; Feldhahn, Magdalena; Wuensche, Julian; Seitz, Christian; Hadaschik, Dirk; Garbe, Claus; Hauser, Till-Karsten; la Fougere, Christian; Biskup, Dirk; Brooke, Dawn; Parker, David; Martens, Uwe M.; Illerhaus, Gerald; Blumenthal, Deborah T.; Merrell, Ryan; Lorenzo, Luisa Sanchez; Hidvegi, Mate; de Robles, Paula; Kebir, Sied; Li, William W.; Li, Vincent W.; Williams, Matthew; Miller, Alexandra M.; Kesari, Santosh; Castro, Michael; Desjardins, Annick; Ashley, David M.; Friedman, Henry S.; Wen, Patrick Y.; Neil, Elisabeth C.; Iwamoto, Fabio M.; Sipos, Bence; Geletneky, Karsten; Zender, Lars; Glas, Martin; Reardon, David A.; Biskup, Saskia

CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study

LEUKEMIA

IF13.4

2024-06-030

OAAI

Kriegsmann, Katharina; Ton, Gigi Nu Hoang Quy; Awwad, Mohamed H. S.; Benner, Axel; Bertsch, Uta; Besemer, Britta; Haenel, Mathias; Fenk, Roland; Munder, Markus; Duerig, Jan; Blau, Igor W.; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Mann, Christoph; Weinhold, Niels; Scheid, Christof; Schroers, Roland; von Metzler, Ivana; Schieferdecker, Aneta; Thomalla, Joerg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M.; Kunz, Christian; Hensel, Manfred; Seidel-Glaetzer, Andrea; Weisel, Katja C.; Salwender, Hans J.; Mueller-Tidow, Carsten; Raab, Marc S.; Goldschmidt, Hartmut; Mai, Elias K.; Hundemer, Michael

ESMO OPEN

IF8.3

2024-05-011

OAAI

Pelareorep plus atezolizumab and chemotherapy in third-line (3L) metastatic colorectal cancer (mCRC) patients: Interim results from the GOBLET study

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Pelareorep (pela) plus atezolizumab (atezo) and chemotherapy in first-line (1L) advanced or metastatic pancreatic ductal adenocarcinoma (PDAC) patients: Results from the GOBLET study

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

User-Centered Development of a Mobile App to Assess the Quality of Life of Patients With Cancer: Iterative Investigation and Usability Testing

JMIR CANCER

IF2.7

2023-09-263

Randomized phase-III study of low-dose cytarabine and etoposide? plus ?/- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia

SCIENTIFIC REPORTS

IF3.9

2023-09-080

OAAI

Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial

NPM1-mutated急性髓系白血病患者接受或不接受吉妥珠单抗ozogamicin的强化化疗 (AMLSG 09-09): 一项随机、开放标签、多中心、3期试验

LANCET HAEMATOLOGY

IF17.7

2023-07-0131

PRE

Doehner, Hartmut; Weber, Daniela; Krzykalla, Julia; Fiedler, Walter; Kuehn, Michael W. M.; Schroeder, Thomas; Mayer, Karin; Luebbert, Michael; Wattad, Mohammed; Goetze, Katharina; Fransecky, Lars; Koller, Elisabeth; Wulf, Gerald; Schleicher, Jan; Ringhoffer, Mark; Greil, Richard; Hertenstein, Bernd; Krauter, Juergen; Martens, Uwe M.; Nachbaur, David; Abu Samra, Maisun; Machherndl-Spandl, Sigrid; Basara, Nadezda; Leis, Claudia; Schrade, Anika; Kapp-Schwoerer, Silke; Cocciardi, Sibylle; Bullinger, Lars; Thol, Felicitas; Heuser, Michael; Paschka, Peter; Gaidzik, Verena I.; Saadati, Maral; Benner, Axel; Schlenk, Richard F.; Doehner, Konstanze; Ganser, Arnold

The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice

INFINITY研究方案: 生物标志物驱动的精准肿瘤学在常规临床实践中的决策和临床影响的回顾性队列研究

BMC CANCER

IF3.4

2023-06-130

OAAI

Uwe M. Martens

个人简介

教育背景

工作经历

荣誉奖项

研究方向